鴻達興業(002002.SZ)累計收到烏海化工分紅款1.96億元
格隆匯12月26日丨鴻達興業(002002.SZ)公佈,公司及下屬子公司生產經營狀況良好,各項業務穩健發展。為實現股東投資收益,日前公司全資子公司內蒙古烏海化工有限公司(“烏海化工”)經其股東決定,以其截止2019年9月30日賬面未分配利潤向公司進行分配,具體分配情況如下:
烏海化工以現金方式向公司分配利潤1.96億元,公司已於2019年12月25日累計收到烏海化工的分紅款1.96億元。此次所得分紅將增加母公司2019年度淨利潤,不增加公司2019年度合併報表淨利潤。
根據烏海化工截至2019年9月30日的財務報表(未經審計),烏海化工(合併)未分配利潤為約21.00億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.